Achieve Life Sciences Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| 149.2 | 284.4 | – | 56.2 | – | 173.9 | – | – | – | – | – | – | – | 23.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 15.3 | 15.0 | 11.5 | 1.9 | 14.8 | 10.8 | 1,147.6 | 3,659.5 | 0.3 | 18.5 | 10.0 | 0.8 | 0.8 | 5.0 | 8.7 | 20.7 | 8.8 | 4.1 | 1.5 | 1.7 | 3.0 | – | – | – | – | – | – | – | – | – | |
| 15.1 | 15.4 | 7.8 | 2.2 | 0.7 | 6.4 | 1.8 | 4.7 | 3.9 | 4.3 | 5.2 | 0.5 | 1.5 | 5.5 | 2.7 | 3.7 | 2.7 | 3.3 | 1.2 | 0.8 | 0.8 | 0.8 | 0.3 | 0.2 | 0.6 | 2.3 | 3.2 | – | 5.4 | 10.1 | |
| 15.2 | 15.0 | 9.1 | 0.9 | 10.6 | 11.3 | 1,138.0 | 3,597.2 | 0.3 | 12.5 | 8.4 | – | 0.5 | 2.6 | 7.0 | 15.8 | 8.0 | 3.6 | 0.5 | -0.2 | 0.1 | – | – | – | – | – | – | – | – | – | |
| 119.9 | 406.0 | – | 18.1 | – | 208.3 | – | – | – | – | – | – | – | 46.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 84.6 | 1,422.2 | – | – | – | 88.9 | – | – | – | – | – | – | – | 3.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.2% | 0.1% | -18.5% | -0.4% | -66.5% | 1.1% | -39.4% | -11.6% | -20.1% | -5.6% | -9.1% | -151.8% | -74.4% | 27.6% | -22.8% | -17.9% | -24.7% | -29.7% | -41.8% | -30.2% | -198.0% | -146.1% | -253.3% | -349.4% | -61.3% | -46.5% | -141.9% | -30.1% | -26.5% | -22.7% | |
| Margins | ||||||||||||||||||||||||||||||
| 103.0% | 103.2% | 115.7% | 105.0% | -803.5% | 40.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | |
| 9.6% | 0.5% | -233.3% | 7.4% | -1,771.0% | 2.5% | -48,696.4% | -42,552.6% | -6.3% | -264.2% | -117.4% | -75.7% | -31.1% | -9.7% | -108.3% | -405.5% | -129.3% | -118.2% | -108.7% | -103.3% | -418.6% | – | – | – | – | – | – | – | – | – | |
| 10.2% | 5.3% | -219.6% | 3.3% | -525.8% | 6.2% | -46,543.2% | -41,868.4% | -6.2% | -255.6% | -105.2% | -64.9% | -20.9% | 21.4% | -92.4% | -267.0% | -105.0% | -106.6% | -96.8% | -92.5% | -397.6% | – | – | – | – | – | – | – | – | – | |
| 18.1% | 1.1% | -211.8% | -0.8% | -982.5% | 12.1% | -45,218.9% | -42,384.8% | -5.7% | -102.7% | -91.4% | -122.9% | -61.1% | 136.5% | -197.6% | -370.1% | -217.9% | -121.1% | -64.1% | -52.2% | -587.3% | – | – | – | – | – | – | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||
| 10.1% | 5.4% | -149.3% | 4.0% | -25.2% | 3.7% | -74.0% | -54.2% | -85.5% | -59.8% | -54.7% | -40.9% | -39.3% | 23.9% | -28.5% | -47.5% | -31.9% | -85.6% | -77.0% | -44.9% | -106.1% | -134.3% | -80.3% | -89.4% | -39.3% | -117.3% | -504.3% | – | -190.6% | -254.0% | |
| 6.3% | 3.5% | -59.6% | 2.2% | -15.0% | 3.4% | -64.9% | -48.8% | -72.3% | -36.4% | -34.4% | -28.9% | -28.4% | 7.9% | -14.0% | -21.6% | -25.7% | -57.2% | -46.6% | -28.9% | -73.3% | -107.0% | -66.5% | -76.6% | -36.4% | -69.2% | -139.7% | -153.9% | -103.1% | -130.8% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| -2.0 | -0.2 | -12 | -12 | -1.7 | 4.5 | -0.2 | -1.6 | -0.3 | -49 | -36 | – | -7.0 | -61 | -22 | -27 | -17 | -14 | -27 | -34 | -14 | -5.3 | -9.5 | -16 | -36 | -28 | 7.5 | 1.2 | -2.8 | -6.0 | |
| -1.0 | -0.3 | – | -20.0 | – | 9.6 | – | – | – | – | – | – | – | -42.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 62.7% | 64.0% | 39.9% | 55.2% | 59.5% | 92.4% | 87.7% | 89.9% | 84.5% | 60.9% | 62.8% | 70.5% | 72.4% | 33.3% | 49.1% | 45.4% | 80.7% | 66.8% | 60.5% | 64.3% | 69.0% | 79.7% | 82.8% | 85.6% | 92.5% | 59.0% | 27.7% | -7.5% | 54.1% | 51.5% | |
| 0.3 | 0.3 | 0.7 | 0.5 | 0.6 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 3.9 | – | 0.5 | 0.7 | |
| Per Share | ||||||||||||||||||||||||||||||
| 7,906.98 | 4,608.29 | -51,612.90 | 1,762.11 | -8,873.71 | 1,844.14 | -33,726.96 | -23,106.18 | -30,260.84 | -27,363.19 | -25,323.97 | -13,971.30 | -1,677.57 | 2,124.95 | -3,938.65 | -3,318.18 | -3,432.80 | -4,772.10 | -3,189.89 | -1,413.63 | -1,474.98 | -441.47 | -72.29 | -39.15 | -5.39 | -4.05 | -3.95 | -1.50 | -1.24 | -1.25 | |
| 77,209.30 | 87,096.77 | 23,502.30 | 53,303.96 | 1,687.63 | 29,756.93 | 72.46 | 55.19 | 491,580.71 | 10,706.20 | 24,077.27 | 21,530.12 | 8,033.12 | 9,910.36 | 4,261.66 | 1,242.88 | 3,269.61 | 4,477.37 | 3,296.38 | 1,527.98 | 370.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 78,139.53 | 85,253.46 | 34,562.21 | 44,052.86 | 35,163.13 | 49,881.39 | 45,576.60 | 42,626.23 | 35,393.66 | 45,737.73 | 46,281.65 | 34,122.37 | 4,272.55 | 8,909.20 | 13,810.64 | 6,985.53 | 10,772.37 | 5,575.52 | 4,140.41 | 3,150.19 | 1,389.76 | 328.68 | 90.03 | 43.78 | 13.71 | 3.45 | 0.78 | -0.07 | 0.65 | 0.49 | |
| 13,953.49 | 921.66 | -49,769.59 | -440.53 | -16,581.64 | 3,609.36 | -32,767.34 | -23,391.17 | -27,915.82 | -10,996.96 | -22,010.69 | -26,450.68 | -4,912.21 | 13,528.52 | -8,421.91 | -4,600.18 | -7,123.98 | -5,421.04 | -2,114.03 | -796.97 | -2,178.43 | -379.90 | -60.79 | -37.03 | -4.96 | -3.63 | -3.55 | -1.24 | -0.93 | -1.13 | |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.